Corporate ActionJul 2, 2026, 04:21 PM
IceCure Medical to Vote on Warrant Amendments, Exercise Price Cut to $3.00
AI Summary
IceCure Medical Ltd. announced a Special General Meeting of Shareholders on August 6, 2026, to approve amendments to its Series B and Series C warrants. The proposed changes include reducing the exercise price from $16.50 to $3.00 per share and extending the exercise periods for both warrant series. These amendments are part of an agreement with an investor and require shareholder approval.
Key Highlights
- Special General Meeting of Shareholders scheduled for August 6, 2026.
- Shareholders to vote on amendments to Series B and Series C warrants.
- Proposed exercise price reduction from $16.50 to $3.00 per share.
- Series B Warrants exercise period extended to June 18, 2031.
- Series C Warrants exercise period extended to June 18, 2027.
- Amendments are subject to shareholder approval.
- Original warrants issued in March 2026 private placement.
Price Impact
More from ICCM